New prostate injection aims to help men pee better
NCT ID NCT07381127
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a liquid called INTUPRO that is injected into the prostate to shrink tissue and improve urine flow in men with enlarged prostate (BPH). 31 men aged 45+ with moderate to severe symptoms will receive the treatment and be followed for 3 months. The goal is to see if it reduces nighttime bathroom trips, hesitancy, and urgency, and helps remove the urinary catheter.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- INTUPRO ionic fluid (a liquid injected into the prostate to shrink tissue)
- What this could lead to
- If it works, this could offer a new, minimally invasive option to relieve BPH symptoms without surgery.
- What could go wrong
- This is a very small, early study with no control group, so results may not be reliable. Risks include infection, bleeding, and urinary retention.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BPH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Koç University Hospital Research Center
RECRUITINGIstanbul, 34010, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Needle-Free prostate treatment match implant surgery?
- Can sound waves offer a lasting fix for prostate problems?
- Robotic precision could transform prostate surgery
- Can a disposable scope make prostate surgery faster and cheaper?
- Simple exercise before prostate surgery may prevent incontinence
- Leg patch may ease bladder troubles after prostate surgery